获取用于治疗非传染性疾病的药物。
Access to drugs for treatment of noncommunicable diseases.
机构信息
Council on Foreign Relations, Washington, DC, United States of America.
出版信息
PLoS Med. 2013;10(7):e1001485. doi: 10.1371/journal.pmed.1001485. Epub 2013 Jul 23.
Abstract
Thomas Bollyky explains the emerging controversy over patented medicines for noncommunicable diseases and their affordability in developing countries. Another transformation in global health is required that focuses on low-cost interventions and patient-centered, rather than country-focused, strategies.
摘要
托马斯·布利基（Thomas Bollyky）解释了新兴的非传染性疾病专利药物及其在发展中国家的可负担性争议。全球卫生领域需要进行另一次转型，重点关注低成本干预措施和以患者为中心的策略，而不是以国家为中心的策略。
相似文献
1
Access to drugs for treatment of noncommunicable diseases.获取用于治疗非传染性疾病的药物。
PLoS Med. 2013;10(7):e1001485. doi: 10.1371/journal.pmed.1001485. Epub 2013 Jul 23.
2
TRIPS, pharmaceutical patents, and access to essential medicines: a long way from Seattle to Doha.《与贸易有关的知识产权协定》、药品专利与基本药物的获取：从西雅图到多哈的漫长之路
Chic J Int Law. 2002 Spring;3(1):27-46.
3
Questions raised about whether compulsory licenses get best prices.关于强制许可是否能获得最优价格的问题被提了出来。
Nat Med. 2015 Apr;21(4):300. doi: 10.1038/nm0415-300.
4
TRIPS, pharmaceuticals, developing countries, and the Doha "solution".《与贸易有关的知识产权协定》、药品、发展中国家与多哈“解决方案”
Chic J Int Law. 2002 Spring;3(1):47-68.
5
Academic patents and access to medicines in developing countries.学术专利与发展中国家的药品可及性。
Am J Public Health. 2009 Jan;99(1):9-17. doi: 10.2105/AJPH.2007.128769. Epub 2008 Nov 13.
6
UK Commission concludes international patent laws hinder access to medicines in developing countries.英国委员会得出结论，国际专利法阻碍了发展中国家获取药品。
Can HIV AIDS Policy Law Rev. 2002 Dec;7(2-3):59.
7
Delivering drugs to the poor: will the TRIPS Amendment help?为贫困人口提供药品：《与贸易有关的知识产权协定》修正案会有所帮助吗？
Am J Law Med. 2008;34(2-3):107-24. doi: 10.1177/009885880803400202.
8
Global "hold-em".全球“梭哈”。
Geriatr Nurs. 2006 Jan-Feb;27(1):21-3. doi: 10.1016/j.gerinurse.2005.09.012.
9
Tripping over patents: AIDS, access to treatment and the manufacturing of scarcity.专利绊脚：艾滋病、治疗可及性与制造稀缺
Conn J Int Law. 2002 Spring;17(2):157-248.
10
More drugs, less protection.药物越多，保护越少。
Nature. 2002 Sep 19;419(6904):233. doi: 10.1038/419233a.
引用本文的文献
1
Service availability and readiness of tuberculosis units' clinics to manage diabetes mellitus in Lubumbashi, Democratic Republic of the Congo.刚果民主共和国卢本巴希结核病防治单位诊所管理糖尿病的服务可及性与准备情况。
BMC Health Serv Res. 2025 Feb 11;25(1):233. doi: 10.1186/s12913-025-12368-7.
2
Readiness of the primary health care units and associated factors for the management of hypertension and type II diabetes mellitus in Sidama, Ethiopia.埃塞俄比亚锡达玛初级卫生保健单位对高血压和 2 型糖尿病管理的准备情况及其相关因素。
PeerJ. 2022 Aug 25;10:e13797. doi: 10.7717/peerj.13797. eCollection 2022.
3
Readiness of health facilities for the outpatient management of non-communicable diseases in a low-resource setting: an example from a facility-based cross-sectional survey in Tanzania.资源匮乏地区卫生设施对非传染性疾病门诊管理的准备情况：以坦桑尼亚一项基于机构的横断面调查为例
BMJ Open. 2020 Nov 11;10(11):e040908. doi: 10.1136/bmjopen-2020-040908.
4
Affordability Assessment from a Static to Dynamic Concept: A Scenario-Based Assessment of Cardiovascular Medicines.从静态到动态概念的负担能力评估：心血管药物的基于情景的评估。
Int J Environ Res Public Health. 2020 Mar 5;17(5):1710. doi: 10.3390/ijerph17051710.
5
Does the political will exist to bring quality-assured and affordable drugs to low- and middle-income countries?是否存在将质量有保证且价格可承受的药品带给低收入和中等收入国家的政治意愿？
Glob Health Action. 2019;12(1):1586317. doi: 10.1080/16549716.2019.1586317.
6
Proposing Essential Medicines to Treat Cancer: Methodologies, Processes, and Outcomes.提出治疗癌症的基本药物：方法、流程与结果。
J Clin Oncol. 2016 Jan 1;34(1):69-75. doi: 10.1200/JCO.2015.61.8736. Epub 2015 Nov 17.
7
Mobile phone text messaging interventions for HIV and other chronic diseases: an overview of systematic reviews and framework for evidence transfer.用于艾滋病病毒及其他慢性病的手机短信干预措施：系统评价综述与证据转化框架
BMC Health Serv Res. 2015 Jan 22;15:33. doi: 10.1186/s12913-014-0654-6.
8
The role of law and governance reform in the global response to non-communicable diseases.法律和治理改革在全球应对非传染性疾病中的作用。
Global Health. 2014 Jun 5;10:44. doi: 10.1186/1744-8603-10-44.
9
Medicalization of global health 3: the medicalization of the non-communicable diseases agenda.全球健康的医学化3：非传染性疾病议程的医学化。
Glob Health Action. 2014 May 16;7:24002. doi: 10.3402/gha.v7.24002. eCollection 2014.
本文引用的文献
1
Promotion of access to essential medicines for non-communicable diseases: practical implications of the UN political declaration.促进获得非传染性疾病基本药物：联合国政治宣言的实际意义。
Lancet. 2013 Feb 23;381(9867):680-9. doi: 10.1016/S0140-6736(12)62128-X. Epub 2013 Feb 12.
2
Trends in compulsory licensing of pharmaceuticals since the Doha Declaration: a database analysis.《多哈宣言》之后药品强制许可的趋势：数据库分析。
PLoS Med. 2012 Jan;9(1):e1001154. doi: 10.1371/journal.pmed.1001154. Epub 2012 Jan 10.
3
Differences in the availability of medicines for chronic and acute conditions in the public and private sectors of developing countries.发展中国家公共部门和私营部门可获得的慢性和急性疾病药物存在差异。
Bull World Health Organ. 2011 Jun 1;89(6):412-21. doi: 10.2471/BLT.10.084327. Epub 2011 Mar 14.
4
Driving a decade of change: HIV/AIDS, patents and access to medicines for all.推动十年变革：艾滋病毒/艾滋病、专利与全民获得药物。
J Int AIDS Soc. 2011 Mar 27;14:15. doi: 10.1186/1758-2652-14-15.
5
Advancing drug innovation for neglected diseases-criteria for lead progression.推进针对被忽视疾病的药物创新——先导化合物进展标准
PLoS Negl Trop Dis. 2009 Aug 25;3(8):e440. doi: 10.1371/journal.pntd.0000440.
6
A new global commitment to disease control in Africa.一项关于非洲疾病控制的新的全球承诺。
Nat Med. 2001 May;7(5):521-3. doi: 10.1038/87830.
Zotero 插件